Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined strategies to accelerate onchocerciasis elimination in Cameroon
ISRCTN13434450Phase 3Active, not recruiting
- Sponsor
- University of Buea
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of doxycycline and ivermectin in onchocerciasis (4 arms), sponsored by University of Buea. Primary endpoint: Absence of live female worms with normal embryogenesis at 20 months. Started Jul 2025; status: active, not recruiting.
02
Drugs
doxycyclineivermectin
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on ISRCTN13434450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13434450.